Authors
Latest:
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC“[These are] very good numbers for these patients who otherwise would undergo a radical cystectomy," says Félix Guerrero-Ramos, MD, PhD, FEBU.
Latest:
Mayo study finds dietary habits that may help prevent kidney stones"Knowing the dietary factors that are most important for preventing kidney stone recurrence can help patients and providers know what to prioritize,” said Andrew Rule, MD.
Latest:
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsyThe risk of stricture formation was 4.6% in the TFL cohort vs 2.4% in the holmium laser cohort.
Latest:
Special Report: Tips for PCPs on evaluating prostate cancer riskIn this video, part 4 of a 4-part series, panelists discuss how primary care providers can address patient questions on prostate cancer screening.
Latest:
Survey highlights communication gaps with kidney cancer diagnosis and care“This indicates opportunities to improve communication about diagnosis, psychosocial impacts, and clinical trials, as well as biopsies, physical exercise, and patient engagement,” wrote Rachel H. Giles, PhD, and colleagues.
Latest:
Future of BCG in NMIBCPanelists discuss how it would be preferred that BCG monotherapy not remain the first-line treatment for intermediate-risk and high-risk disease within the next 10 years. It is encouraged that the future of first-line treatment be a noninfectious agent that would be easier to develop and include more data.
Latest:
Paul Sieber, MD, on the future of genetic testing in prostate cancerSieber shares his thoughts on the potential for universal genetic testing to become a standard of care practice for patients with prostate cancer.
Latest:
Interpreting PSA Trends in Patients Receiving Darolutamide Plus ADT With mHSPCExploring the impact of ultra-sensitive PSA testing on treatment decisions for metastatic hormone-sensitive prostate cancer, enhancing patient outcomes and care efficiency.
Latest:
Case 4: Metastatic Castration-Resistant Prostate Cancer With an HRR AlterationPanelists discuss how the management of metastatic castration-resistant prostate cancer with a homologous recombination repair (HRR) alteration involves targeted therapies, such as PARP inhibitors, to exploit the genetic vulnerability and improve treatment response.
Latest:
Future Directions in PSMA-PET ImagingLooking to the future treatment landscape in prostate cancer, the panel provides closing thoughts on the trajectory of the utilization of PSMA-PET imaging and the unmet needs it might address.
Latest:
Experts consider efficacy of fertility restoration vs sperm cryopreservation“While I would hesitate to say that reversal is truly better in terms of efficacy, I think this data suggests that it's at least as good,” says Scott D. Lundy, MD, PhD, HCLD.
Latest:
Financial toxicity is a growing concern in urologic oncology"Clinicians have opportunities to reduce patient subjective and objective financial burden if they continue to self-educate and communicate with patients and consider [financial toxicitiy] an adverse effect of treatment," write Alexandria A. Spellman, MD, MS, and Deborah R. Kaye, MD, MS.
Latest:
Naeem Bhojani, MD, expands on key findings from WATER III trial“I think it will help patients decide what prostate surgery they want,” says Naeem Bhojani, MD, FRCSC.
Latest:
Future Directions in PSMA-PET ImagingLooking to the future treatment landscape in prostate cancer, the panel provides closing thoughts on the trajectory of the utilization of PSMA-PET imaging and the unmet needs it might address.
Latest:
13 tips to keep your patient data safe from hackersHere are 13 cybersecurity measures medical practices can take to protect patient data from hackers.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Practice Management: Expert coding tipsA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment.
Latest:
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists"There was a significant increase in overall fatigue after performing flexible ureteroscopy," says Sarah Razavi, MD.
Latest:
Gopa Iyer, MD, highlights SURF301 trial of TYRA-300 in mUC"The preliminary results of that study, which is a phase 1/2 dose escalation and dose expansion trial, were presented by Professor Ben Tran last year at the ENA meeting1 and showed a very favorable toxicity profile compared to erdafitinib," says Gopa Iyer, MD.
Latest:
Pearls & Perspectives: Premature ejaculation, with Brian L. Steixner, MDHost Amy Pearlman, MD, discusses premature ejaculation with Brian L. Steixner, MD, a board-certified urologist in Linwood, New Jersey.
Latest:
Jason Scovell, MD, on clinical utility of IsoPSA across racial groupsThe test demonstrated comparable or superior performance in Black and Non-White men.
Latest:
Vaginal prolapse repair and sling surgery significantly reduce UUI"The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.
Latest:
Managing BCG-Unresponsive NMIBC: Cretostimogene Monotherapy vs. Combination TherapyPanelists discuss their views on using cretostimogene as monotherapy versus combination therapy, the importance for urologists to stay updated on advances for managing BCG-unresponsive NMIBC, and the potential impact of combining cretostimogene with pembrolizumab on addressing unmet needs in NMIBC care.
Latest:
Upper tract urothelial carcinoma case illustrates rapidly changing treatment landscapeUrologists and medical oncologists should collaborate to tailor therapy to the specific needs of the patient.
Latest:
Management of recurrent prostate cancer after focal therapyProviders must carefully consider treatment options to align with patient preference.
Latest:
Cutting drug costs for patients: key takeaways for urologists"The Inflation Reduction Act was a major step in the right direction. The question now is going to be, are commercial insurers going to follow Medicare and enact the same cap that they have as well," says Benjamin Pockros, MD, MBA.
Latest:
Ronney Abaza, MD, on robotic surgery at ultralow pressures“In that randomized trial, we have level 1 evidence showing that patients have less pain and faster return of bowel function when you work at low pressure,” says Ronney Abaza, MD.
Latest:
Fertility preservation in patients with testicular cancer"Full discussion of the various fertility preservation options and an understanding of the fertility implications of the various treatment modalities must be understood by patients for them to make optimal decisions for their reproductive futures," write the authors.
Latest:
What is needed to advance the use of natural products in prostate cancer?"The most critical next step is to focus on enhancing both the scientific rigor of our clinical trials and the personalization of our treatment," says Channing J. Paller, MD.
Latest:
Urology Practice advice: Real estate pitfalls to avoidCommercial real estate can be one of the highest expenses for health care practices.
